Evidence map›Paper›PMID 25323133›Full record

ReviewCellular and molecular life sciences : CMLS2015

Cell death controlling complexes and their potential therapeutic role.

Alexey V Zamaraev, Gelina S Kopeina, Boris Zhivotovsky, Inna N Lavrik

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Molecular Cell Biology of Apoptosis in Health and Disease.Advances in experimental medicine and biology · 2025
    Review
  3. Review
  4. Article
  5. Targeting STAT3 Enzyme for Cancer Treatment.Mini reviews in medicinal chemistry · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexey V ZamaraevFaculty of Basic Medicine, MV Lomonosov Moscow State University, 119991, Moscow, Russia.
Gelina S KopeinaFaculty of Basic Medicine, MV Lomonosov Moscow State University, 119991, Moscow, Russia.
Boris ZhivotovskyFaculty of Basic Medicine, MV Lomonosov Moscow State University, 119991, Moscow, Russia. Boris.Zhivotovsky@ki.se.
Inna N LavrikFaculty of Basic Medicine, MV Lomonosov Moscow State University, 119991, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmed cell death plays a central role in the regulation of homeostasis and development of multicellular organisms. Deregulation of programmed cell death is connected to a number of disorders, including cancer and autoimmune diseases. Initiation of cell death occurs in the multiprotein complexes or high molecular weight platforms. Composition, structure, and molecular interactions within these platforms influence the cellular decision toward life or death and, therefore, define the induction of a particular cell death program. Here, we discuss in detail the key cell-death complexes-including DISC, complex II, and TNFRI complex I/II, and the necrosome, RIPoptosome, apoptosome, and PIDDosome-that control apoptosis or necroptosis pathways as well as their regulation. The possibility of their pharmacological targeting leading to the development of new strategies of interference with cell death programs via control of the high molecular weight platforms will be discussed.

Indexed as

Models, BiologicalApoptosomesCaspase 2Cell DeathDeath Domain Receptor Signaling Adaptor ProteinsMultiprotein ComplexesNecrosisSignal TransductionApoptosomesCaspase 2Death Domain Receptor Signaling Adaptor ProteinsMultiprotein Complexes

Identifiers

PMID25323133
PMCPMC11113151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.